To support the ongoing research efforts on Coronavirus SARS-CoV-2 causing COVID-19 disease, we've provided easy access to critical products needed for virus research and detection...
Een goed functionerend laboratorium voor kwaliteitscontrole zorgt voor de integriteit van het productieproces van een bedrijf, van validatie van grondstoffen tot en met de controle van eindproducten...
VWR staat al bekend als topleverancier van gespecialiseerde kleuringsmaterialen voor de pathologiemarkt. Dagelijks werken we aan het opbouwen van onze productportfolio voor klinische klanten...
Nieuw Avantor® J.T.Baker® premium geleidende en niet-geleidende robottips leveren superieure kwaliteit en betrouwbare prestaties voor resultaten waarop u kunt vertrouwen.
Avantor Services provides a wide range of specialized services and digital solutions to help you solve complex challenges.
We’ve built our reputation on consistent, comprehensive mastery of day-to-day operations, allowing lab, clinical, and production environments to focus their high-value resources on core scientific priorities.
As our customers’ needs have evolved, so have our capabilities. We have become experts in scientific operations, improving performance with sophisticated solutions and providing guidance on best practices.
You can select and customize services for peak efficiency, quality, and accelerated innovation.
De unieke positie die Avantor inneemt op de markt stelt ons niet alleen in staat om u een uitgebreid assortiment equipment aan te bieden, maar ook technische service van internationale topklasse.
Avantor's online ervaring verandert om u beter van dienst te kunnen zijn! Vanaf 4 april 2025 worden klanten overgezet naar een nieuw platform om de digitale winkelervaring te optimaliseren.
In today's fast-paced world of research and development, time is of the essence when it comes to bringing ground-breaking medicines to market. Fortunately, automation has emerged as a powerful tool, empowering researchers to streamline and expedite the process like never before.
During this webinar, we will explore:
How automation is empowering researchers to fast-track novel medicines’ time to market,
Ways to overcome common challenges in microbiology and cell line development, regardless of where in the journey,
How we can learn from expert best practices with automated colony-picking workflows and how they plan to increase adoption in their operations.
Register now and embark on a journey towards faster, more efficient drug discovery and development.
Presented by:
Janet Graystone EU Sales Manager BioPharma
Janet joined Molecular Devices in April 2019 as a Workflow Solutions Specialist and now leads the European BioPharma Team for Molecular Devices as a Sales Manager. Her career started as a Research Scientist at the University of Bath. Janet quickly moved into commercial roles in the industry, such as Miltenyi Biotech and Life Technologies, where she worked as a Senior Field Application Scientist and Product Manager, as well as doing Business Development for TTP Labtech across Europe. Janet holds a Bachelor’s degree in Applied Biology and an M.Sc in Immunology and has over 20 years of experience working in the Biopharma and automation sectors.
Carola Mancini Ph.D EU Field Application Scientist BioPharma
Carola joined Molecular Devices in September 2021 as Field Application Scientist specializing in automated end-to-end workflow solutions in cell line development, monoclonal antibodies, CRISPR gene editing, and synthetic biology. Carola holds an M.Sc in biotechnology and a Ph.D in Molecular Biology and Cell Physiology. She has researched at the German Institute of Human Nutrition in Potsdam, where she was involved in different cell line engineering projects to study obesity and metabolic disease. In 2016, Carola was involved in a research project investigating potential treatments for prostate cancer at the CIC bioGUNE Research Institute in Biscay, Spain.
Deze website maakt gebruik van cookies, eigen of van derden, om statistische informatie over uw surfgedrag te verzamelen en om advertenties weer te geven die verband houden met uw voorkeuren, gegenereerd op basis van uw surfgedrag. Als u deze site blijft gebruiken, beschouwen wij dit als akkoord voor het gebruik.